Dark Pharma · DP-032
WE RAISED IT NINE TIMES. THE FDA APPROVED ZERO DESIGN CHANGES. EACH INCREASE WAS MODELLED AGAINST CUSTOMER DESPERATION.
Between 2009 and 2016, Veritas Health's LifeGuard epinephrine auto-injector saw its price soar from $103 to $612, despite no changes in product formulation. Each increase was justified based on how much families were willing to pay for their children's safety, ultimately leading to rationing and expired injectors.
Case Assets
The Case Debrief is free to view. Full Case Study, Teaching Notes, Slide Deck, Discussion Guide, and Assessment are available with a Premium subscription.
Brief the Board
PREMIUM
🔒 Unlock
Learn the Case
FREE — included
Study the Case
PREMIUM
🔒 Unlock
Teach the Case
PREMIUM
🔒 Unlock
Present the Case
PREMIUM
🔒 Unlock
Run a Team Discussion
PREMIUM
🔒 Unlock
Test Your Judgement
PREMIUM
🔒 Unlock
Watch the Full Episode
The complete cinematic audio documentary — Dark Pharma
Unlock the Full Case Library
Get every Case Study, Slide Deck, Teaching Notes, Discussion Guide, and Assessment — across a growing library of business cases.
View Pricing →Related Cases
Cases that share a governance or behavioural model with this one.
The Raid
HJ-033
HE COUNTED 2.8 BILLION IN SALES BETWEEN THEM. THE COURT HAD APPROVED E...
Shared: Stakeholder Engagement Model
Dark Law
DL-024
HE STUDIED CONTRACT LAW IN CELL BLOCK D. THE PRISON BOARD APPROVED HIS...
Shared: Stakeholder Engagement Model
B-School Noir
BN-022
HE DESIGNED THE MODULE IN 2012. THE CONTRACTORS PAID FOR THE CHAIRS TH...
Shared: Stakeholder Engagement Model
Machine Room
MX-034
HE CHANGED 689,000 NEWS FEEDS WITHOUT CONSENT. THE UNIVERSITY CALLED I...
Shared: Stakeholder Engagement Model